The FDA granted orphan drug designation to OpCT-001 for the treatment of retinitis pigmentosa, according to a press release from BlueRock Therapeutics.The investigational induced pluripotent stem cell-derived cell therapy is currently being evaluated i…
HEIDELBERG, Germany & CAMBRIDGE, Mass.–(BUSINESS WIRE)– #FDA–Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique water-free EyeSol® drug category, today announced that the U.S. Food and D…
The FDA has authorized urcosimod 0.05% for single-patient expanded access, or compassionate use, in a patient with neuropathic corneal pain, according to a press release from Okyo.The terms of the Investigational New Drug (IND) application stipulate th…
WAIKOLOA, Hawaii — Patients with retinal diseases who were treated with anti-VEGF therapies through manufacturer patient assistance programs showed sustained vision gains and central subfield thickness reduction.During a presentation at Retina 2026, Mu…
On Thursday, HHS announced that the United States has completed its withdrawal from WHO.The process began a year ago when President Donald J. Trump, on the night of his inauguration, announced plans to leave WHO, complaining that the agency demanded to…
WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2026, Audrey Talley Rostov, MD, of Bellevue Precision Vision, discusses how to choose the right IOL.Rostov said surgeons have a lot of factors to consider, such as the ocular surface…